The Effect of Polyoxyethylene–Polyoxypropylene Triblock Copolymers on the Loading Degree of Poly-(Lactic-co-Glycolic Acid) Copolymer-Based Microparticles Containing Chlorin e6 and Ethidium Bromide in Mesenchymal Stem Cells


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The effect of different polyoxyethylene–polyoxypropylene triblock copolymers, their concentration, and mode of action on the loading of poly-(lactic-co-glycolic acid) copolymer-based microparticles containing such medicinal agents as radachlorin (chlorin e6) or ethidium bromide in mesenchymal stem cells was studied. It has been shown that medicinal agents encapsulated inside microparticles affect the loading of these particles in the cytoplasm of mesenchymal stem cells. The number of cells that absorbed the particles with chlorin e6 is approximately two times lower than that in the experiments with ethidium bromide. It has been shown that pretreatment of microparticles with triblock copolymers is more efficient for loading them in cells compared with simultaneous introduction of triblock copolymers and particles into the culture medium. Treatment of ethidium bromide-containing microparticles with triblock copolymers is not efficient for their loading in mesenchymal stem cells compared to the control. The exception is Pluronic 123; when particles are treated with it at concentrations of 1 and 2%, the loading of particles in cells increases compared to the control by factors of approximately 11 and 5, respectively. For particles with chlorin e6, their pretreatment with triblock copolymers at a concentration of 4% is most efficient; the loading of the pretreated particles in cells is increased by factors of approximately 3 to 11.

作者简介

A. Temnov

Institute of Cell Biophysics, Federal Research Center Pushchino Scientific Center of Biological Investigations, Russian Academy of Sciences; Moscow Institute of Physics and Technology (State University); Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia

Email: nikukushkin@mail.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290; Dolgoprudny, Moscow oblast, 141701; Moscow, 123098

A. Sklifas

Institute of Cell Biophysics, Federal Research Center Pushchino Scientific Center of Biological Investigations, Russian Academy of Sciences

Email: nikukushkin@mail.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290

N. Kukushkin

Institute of Cell Biophysics, Federal Research Center Pushchino Scientific Center of Biological Investigations, Russian Academy of Sciences

编辑信件的主要联系方式.
Email: nikukushkin@mail.ru
俄罗斯联邦, Pushchino, Moscow oblast, 142290

S. Krechetov

Moscow Institute of Physics and Technology (State University)

Email: nikukushkin@mail.ru
俄罗斯联邦, Dolgoprudny, Moscow oblast, 141701

E. Gorina

Moscow Institute of Physics and Technology (State University)

Email: nikukushkin@mail.ru
俄罗斯联邦, Dolgoprudny, Moscow oblast, 141701

T. Astrelina

Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia

Email: nikukushkin@mail.ru
俄罗斯联邦, Moscow, 123098

D. Usupzhanova

Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia

Email: nikukushkin@mail.ru
俄罗斯联邦, Moscow, 123098

Yu. Suchkova

Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia

Email: nikukushkin@mail.ru
俄罗斯联邦, Moscow, 123098

I. Kobzeva

Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia

Email: nikukushkin@mail.ru
俄罗斯联邦, Moscow, 123098

A. Samoilov

Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency of Russia

Email: nikukushkin@mail.ru
俄罗斯联邦, Moscow, 123098

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Inc., 2019